Northwest & Ethical Investments’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$208K Buy
3,700
+2,900
+363% +$163K 0.01% 449
2025
Q1
$32.3K Buy
+800
New +$32.3K ﹤0.01% 469